Recommended
product-img
  • Products
  • Discover MP Targets
  • Discover Research Areas
  • mProX™ Human ANO1 Stable Cell Line

    [CAT#: S01YF-1023-PY257]
    Product Category:
    Membrane Protein Stable Cell Lines
    Subcategory:

    Datasheet MSDS Request COA

    Certificate of Analysis Lookup
    To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
    Lot Number

    Made to Order Inquiry

    Inquiry
    Host Cell Type:
    Membrane Protein Engineering:
    Fluorescent Marker:
    Resistance:
    Deliverable:

    Product Information

    Target Family
    Other Targets
    Target Protein Species
    Human
    Host Cell Type
    HEK293;CHO-K1;PC-3;RWPE-1
    Target Classification
    Other Targets Drug Discovery Assays and Products
    Target Research Area
    Digestive and Renal Research
    Related Diseases
    Intestinal Dysmotility Syndrome; Gastric Leiomyoma
    Gene ID
    Human:55107
    UniProt ID
    Human:Q5XXA6

    Product Properties

    Biosafety Level
    Level 1
    Activity
    Yes
    Quantity
    10⁶ cells per vial
    Applications
    The calcium-activated chloride channel ANO1 has been studied in various contexts. In one study, it was found that ANO1 may play a protective role in amyotrophic lateral sclerosis (ALS) by activating EGFR and CaMKII signaling. Another study focused on the role of ANO1 in lymphatic muscle cell pacemaking, specifically in the context of knock-out of Ano1 or IP3R. It was discovered that ANO1 is involved in the rhythmic action potentials and calcium ion concentration in lymphatic vessels. Additionally, ANO1 was investigated in colonic epithelium from cystic fibrosis patients and healthy individuals, where it was found to modulate CFTR activity but not function as an apical anion channel. Lastly, ANO1 was identified as a potential drug target in human pheochromocytoma and paraganglioma, with increased expression observed in these tumors. Overall, ANO1 has been implicated in various cellular processes and diseases, highlighting its potential as a therapeutic target.

    Protocols

    Please visit our protocols page.

    Customer Reviews

    There are currently no Customer reviews or questions for mProX™ Human ANO1 Stable Cell Line (S01YF-1023-PY257). Click the button above to contact us or submit your feedback about this product.

    FAQ

    chat Casey Davis (Verified Customer)

    Does ANO1 overexpression affect cancer cell proliferation? Feb 20 2021

    chat Patrick Liam (Creative Biolabs Scientific Support)

    Overexpression of ANO1 in laryngocarcinoma Hep-2 cells does not significantly alter proliferation but increases migration, spreading, and detachment capacities, indicating its role in cancer cell motility. Feb 20 2021

    chat Morgan Miller (Verified Customer)

    How does ANO1 affect cardiac fibroblast differentiation? Feb 22 2023

    chat Patrick Liam (Creative Biolabs Scientific Support)

    ANO1 expression is closely related to the differentiation of myocardial fibroblasts and may be involved in modulating myocardial fibrosis. Feb 22 2023

    Published Data

    Fig.1 The phosphorylation of FADD is promoted by the silencing of endogenous ANO1.

    In the left panel, immunoblots were observed in lysates derived from PC-3 cells that had been transfected with ANO1-siRNAs or NCsi for a duration of 72 hours. On the right panel, lysates from normal RWPE-1 cells were utilized for the stable expression of ANO1, while the IRES2-GFP vector was employed as the control. A bar graph was constructed to display the quantitative analysis of phospho-FADD and total FADD protein expression in PC-3 cells with ANO1 knockdown.

    Ref: Song, Yan, et al. "Inhibition of ANO1/TMEM16A induces apoptosis in human prostate carcinoma cells by activating TNF-α signaling." Cell Death & Disease 9.6 (2018): 703.

    Pubmed: 29899325

    DOI: 10.1038/s41419-018-0735-2

    Research Highlights

    Wang, Ying. et al. "Researches of calcium-activated chloride channel ANO1 intervening amyotrophic lateral sclerosis progression by activating EGFR and CaMKII signaling." Brain research bulletin, 2023.
    According to recent studies, ANO1 has been found to have a strong correlation with the activation of EGFR and CaMKII. However, in amyotrophic lateral sclerosis (ALS) models, both EGFR and CaMKII exhibit low levels of activation. Based on this observation, the researchers conducted experiments to investigate the potential protective function of ANO1 on motor neurons in ALS, through its ability to activate EGFR and CaMKII. These findings suggest a potential therapeutic target for ALS treatment.
    Wang, Ying. et al. "Researches of calcium-activated chloride channel ANO1 intervening amyotrophic lateral sclerosis progression by activating EGFR and CaMKII signaling." Brain research bulletin, 2023.
    Pubmed: 37858681   DOI: 10.1016/j.brainresbull.2023.110792

    J Hancock, Edward. et al. "A dual-clock-driven model of lymphatic muscle cell pacemaking to emulate knock-out of Ano1 or IP3R." The Journal of general physiology, 2023.
    The lymphatic system is known to be involved in a variety of diseases, including obesity, cardiovascular disease, and neurological disorders like Alzheimer's disease. The returning of fluid through the lymphatic vascular system is primarily facilitated by muscle contractions in the walls of the vessels, which are driven by electrochemical oscillations that cause rhythmic action potentials and surges in calcium ion concentration. However, there is still limited understanding of the underlying mechanisms involved in these events, making it difficult to develop effective pharmacological treatments. In a previous study, the researchers proposed a model where autonomous oscillations in the membrane potential (M-clock) drove passive oscillations in calcium concentration (C-clock). In this paper, the authors extend their model to include active coupled M-clock and C-clock oscillators, which are both responsible for driving the action potentials. This extension was made by modifying the model's description of the IP3 receptor, a crucial mechanism in the C-clock. Through phase-plane analysis, the researchers were able to explain the coupling mechanisms of the dual clocks. The model has the potential to aid in understanding the mechanisms and identifying targets for pharmacological treatment of lymphoedema.
    J Hancock, Edward. et al. "A dual-clock-driven model of lymphatic muscle cell pacemaking to emulate knock-out of Ano1 or IP3R." The Journal of general physiology, 2023.
    Pubmed: 37851028   DOI: 10.1085/jgp.202313355

    Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR CLINICAL PROCEDURES" For licensing inquiries, please contact
    Send Inquiry Send Inquiry
    Inquiry Basket
    compare

    Go to compare